Structural and Functional Characterization of Rare Ocular Diseases
RADIS
1 other identifier
observational
50
1 country
1
Brief Summary
Rare ocular diseases (ROD) are a heterogeneous group of ocular diseases that affect very few people and, generally, for which no tretament is available. An important subgroup of these diseases are inherited retinal degenerations. In this study we focus on understanding the natural history of different ROD that affect the posterior segment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 24, 2021
CompletedFirst Submitted
Initial submission to the registry
February 17, 2022
CompletedFirst Posted
Study publicly available on registry
February 28, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 24, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 24, 2025
CompletedMarch 15, 2022
February 1, 2022
3 years
February 17, 2022
February 28, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in best corrected visual acuity
Change from baseline in BCVA
Year 2 as compared to baseline
Secondary Outcomes (2)
Change in mean macular sensitivity
Year 2 as compared to baseline
Change in retinal thickness
Year 2 as compared to baseline
Eligibility Criteria
Patients with a ROD affecting the posterior segment of the eye
You may qualify if:
- Male or female 18 years or older with a diagnosis of a ROD affecting the posterior segment
- Patients able to undergo all required ophthalmic exams
- Patients able and willing to sign an informed consent
You may not qualify if:
- Patients with other concomitant posterior segment disorders
- Patients taking drugs known to affect the retina and/or optic nerve
- Patients that underwent an intraocular surgery (aside from phacoemulsification with intraocular lens implantation), corneal or glaucoma surgery
- Patients who have participated in the past 12 months or that are currently participating in clinical trials for an ocular disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institut de la màcula
Barcelona, 08022, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
February 17, 2022
First Posted
February 28, 2022
Study Start
November 24, 2021
Primary Completion
November 24, 2024
Study Completion
November 24, 2025
Last Updated
March 15, 2022
Record last verified: 2022-02